AstraZeneca holds talks with Bristol Myers Squibb over £300bn merger ○
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
A deal by AstraZeneca chief executive Sir Pascal Soriot would extend the drugmaker's footprint in the US market.